Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 9Breast Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Ovarian Neoplasms 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Solid Tumor 1Proteinuria 1Peritoneal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer 1Locally Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

anlotinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Proteinuria × Bevacizumab × Clear all
NCT07358520 2026-01-22

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Fudan University

Phase 4 Not yet recruiting
40 enrolled

Proteinuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡